[Feasibility of PEG-rhG-CSF in the first-line treatment of diffuse large B-cell lymphoma receiving dose-adjusted EPOCH plus rituximab].
Zhonghua Xue Ye Xue Za Zhi
; 41(2): 167-170, 2020 Feb 14.
Article
en Zh
| MEDLINE
| ID: mdl-32135637
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Protocolos de Quimioterapia Combinada Antineoplásica
/
Linfoma de Células B Grandes Difuso
Idioma:
Zh
Revista:
Zhonghua Xue Ye Xue Za Zhi
Año:
2020
Tipo del documento:
Article